BioSyent Inc.
BIOYF
$10.61
-$0.09-0.81%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 30.82M | 30.16M | 28.30M | 27.48M | 25.56M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.82M | 30.16M | 28.30M | 27.48M | 25.56M |
| Cost of Revenue | 7.22M | 6.80M | 6.17M | 5.90M | 5.24M |
| Gross Profit | 23.60M | 23.37M | 22.13M | 21.58M | 20.32M |
| SG&A Expenses | 15.59M | 15.21M | 14.46M | 14.34M | 13.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.81M | 22.01M | 20.63M | 20.24M | 18.86M |
| Operating Income | 8.01M | 8.15M | 7.67M | 7.23M | 6.70M |
| Income Before Tax | 8.61M | 8.44M | 7.97M | 7.56M | 7.15M |
| Income Tax Expenses | 2.16M | 2.27M | 2.05M | 1.94M | 1.83M |
| Earnings from Continuing Operations | 6.45 | 6.18 | 5.92 | 5.62 | 5.31 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.45M | 6.18M | 5.92M | 5.62M | 5.31M |
| EBIT | 8.01M | 8.15M | 7.67M | 7.23M | 6.70M |
| EBITDA | 8.51M | 8.57M | 8.01M | 7.58M | 7.01M |
| EPS Basic | 0.57 | 0.55 | 0.52 | 0.49 | 0.46 |
| Normalized Basic EPS | 0.48 | 0.48 | 0.45 | 0.43 | 0.40 |
| EPS Diluted | 0.56 | 0.54 | 0.51 | 0.48 | 0.45 |
| Normalized Diluted EPS | 0.47 | 0.47 | 0.44 | 0.42 | 0.39 |
| Average Basic Shares Outstanding | 45.05M | 45.28M | 45.61M | 45.95M | 46.34M |
| Average Diluted Shares Outstanding | 46.03M | 46.23M | 46.55M | 46.84M | 47.20M |
| Dividend Per Share | 0.14 | 0.14 | 0.14 | 0.13 | 0.13 |
| Payout Ratio | 24.99% | 25.50% | 26.15% | 27.10% | 28.59% |